These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 33068028)

  • 1. Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis.
    Takeuchi T; Chino Y; Mano Y; Kawanishi M; Sato Y; Uchida S; Tanaka Y
    J Clin Pharmacol; 2024 Apr; 64(4):418-427. PubMed ID: 37909264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial.
    Takeuchi T; Tanaka Y; Erdman J; Kaneko Y; Saito M; Higashitani C; Smulders R; Lademacher C
    Arthritis Res Ther; 2020 Oct; 22(1):252. PubMed ID: 33087159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme.
    Cohen SB; Tanaka Y; Mariette X; Curtis JR; Lee EB; Nash P; Winthrop KL; Charles-Schoeman C; Wang L; Chen C; Kwok K; Biswas P; Shapiro A; Madsen A; Wollenhaupt J
    RMD Open; 2020 Oct; 6(3):. PubMed ID: 33127856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study.
    Takeuchi T; Rischmueller M; Blanco R; Xavier RM; Ueki Y; Atsumi T; Chen S; Friedman A; Pangan AL; Strand V; van Vollenhoven RF
    Mod Rheumatol; 2021 May; 31(3):534-542. PubMed ID: 33164611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
    Cohen SB; van Vollenhoven RF; Winthrop KL; Zerbini CAF; Tanaka Y; Bessette L; Zhang Y; Khan N; Hendrickson B; Enejosa JV; Burmester GR
    Ann Rheum Dis; 2021 Mar; 80(3):304-311. PubMed ID: 33115760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan.
    Takeuchi T; Tanaka Y; Tanaka S; Kawakami A; Song YW; Chen YH; Rokuda M; Izutsu H; Ushijima S; Kaneko Y
    Rheumatol Ther; 2021 Mar; 8(1):425-442. PubMed ID: 33656739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of janus kinase inhibitors and methotrexate combination on malignancy in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.
    Solipuram V; Mohan A; Patel R; Ni R
    Auto Immun Highlights; 2021 Apr; 12(1):8. PubMed ID: 33910632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients.
    Fernández-Díaz C; Atienza-Mateo B; Castañeda S; Melero-Gonzalez RB; Ortiz-SanJuan F; Loricera J; Casafont-Solé I; Rodríguez-García S; Aguilera-Cros C; Villa-Blanco I; Raya-Alvarez E; Ojeda-García C; Bonilla G; López-Robles A; Arboleya L; Narváez J; Cervantes E; Maiz O; Alvarez-Rivas MN; Cabezas I; Salgado E; Hidalgo-Calleja C; Fernández S; Fernández JC; Ferraz-Amaro I; González-Gay MA; Blanco R;
    Rheumatology (Oxford); 2021 Dec; 61(1):299-308. PubMed ID: 33779697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care Data.
    Tong DMH; Hughes JH; Keizer RJ
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of peficitinib in two patients with rheumatoid arthritis on maintenance hemodialysis.
    Nishimura A; Tateiwa M; Tajima S; Tada T
    J Rural Med; 2022 Jul; 17(3):193-195. PubMed ID: 35847752
    [No Abstract]   [Full Text] [Related]  

  • 11. Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.
    Yang S; Lukey P; Beerahee M; Hoke F
    Clin Pharmacokinet; 2013 Mar; 52(3):187-98. PubMed ID: 23254770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials.
    Klünder B; Mohamed MF; Othman AA
    Clin Pharmacokinet; 2018 Aug; 57(8):977-988. PubMed ID: 29076110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Lee YH; Song GG
    Clin Drug Investig; 2020 Jan; 40(1):65-72. PubMed ID: 31602572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic analysis of peficitinib in patients with rheumatoid arthritis.
    Toyoshima J; Shibata M; Kaibara A; Kaneko Y; Izutsu H; Nishimura T
    Br J Clin Pharmacol; 2021 Apr; 87(4):2014-2022. PubMed ID: 33068028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure-response modeling of peficitinib efficacy in patients with rheumatoid arthritis.
    Toyoshima J; Kaibara A; Shibata M; Kaneko Y; Izutsu H; Nishimura T
    Pharmacol Res Perspect; 2021 May; 9(3):e00744. PubMed ID: 33929089
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.